Robert Dee Etherington
Chief Executive Officer bij CLENE INC.
Vermogen: 40 082 $ op 31-03-2024
Actieve functies van Robert Dee Etherington
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| CLENE INC. | Director/Board Member | 01-01-2020 | - |
| Chief Executive Officer | 01-04-2013 | - | |
| President | 01-04-2013 | - | |
| BioUtah | Director/Board Member | 01-06-2016 | - |
Clene Nanomedicine, Inc.
 Clene Nanomedicine, Inc. Pharmaceuticals: MajorHealth Technology Clene Nanomedicine, Inc. is a clinical-stage biopharmaceutical company, which develops therapeutic candidates for neurodegenerative diseases. It focuses on the development of therapeutic nanocatalyst, CNM-Au8, for treatment of neurodegenerative diseases with a Phase 3 study underway in amyotrophic lateral sclerosis (ALS), and concurrent Phase 2 clinical programs ongoing for the neuroreparative treatment of multiple sclerosis, Parkinson's disease, and ALS. The company was founded by Reed N. Wilcox and Mark G. Mortenson in 2013 and and is headquartered in Salt Lake City, UT. | Director/Board Member | - | - |
| Chief Executive Officer | 01-04-2013 | - | |
| President | 01-04-2013 | - | |
| Corsair LLC | Director/Board Member | 01-03-2018 | - |
Loopbaan van Robert Dee Etherington
Eerdere bekende functies van Robert Dee Etherington
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Actelion Pharmaceuticals Ltd.
 Actelion Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals Ltd. is a Swiss company that develops and distributes molecular weight drugs. The private company is based in Allschwil, Switzerland. | Sales & Marketing | 01-09-2000 | 01-03-2013 |
Opleiding van Robert Dee Etherington
| Brigham Young University | Masters Business Admin |
Statistieken
Internationaal
| Verenigde Staten | 6 |
| Zwitserland | 2 |
Operationeel
| Director/Board Member | 4 |
| Chief Executive Officer | 2 |
| President | 2 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CLENE INC. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
| BioUtah | |
Clene Nanomedicine, Inc.
Clene Nanomedicine, Inc. Pharmaceuticals: MajorHealth Technology Clene Nanomedicine, Inc. is a clinical-stage biopharmaceutical company, which develops therapeutic candidates for neurodegenerative diseases. It focuses on the development of therapeutic nanocatalyst, CNM-Au8, for treatment of neurodegenerative diseases with a Phase 3 study underway in amyotrophic lateral sclerosis (ALS), and concurrent Phase 2 clinical programs ongoing for the neuroreparative treatment of multiple sclerosis, Parkinson's disease, and ALS. The company was founded by Reed N. Wilcox and Mark G. Mortenson in 2013 and and is headquartered in Salt Lake City, UT. | Health Technology |
Actelion Pharmaceuticals Ltd.
Actelion Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals Ltd. is a Swiss company that develops and distributes molecular weight drugs. The private company is based in Allschwil, Switzerland. | Health Technology |
| Corsair LLC |
